Christopher Ryan Sullivan - Insider Trading & Ownership

Location
C/O Cerecor Inc., 400 E. Pratt Street, Suite 606, Baltimore, MD
Summary
The estimated net worth of Christopher Ryan Sullivan is at least $553K dollars as of April 1, 2025. Christopher Ryan Sullivan is the Chief Financial Officer of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $553K.
Signature
/s/ Donald R. Reynolds, by Power of Attorney
All Insider Reports
All Insider Reports

Ownership of Christopher Ryan Sullivan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AVTX Avalo Therapeutics, Inc. Chief Financial Officer $553K Mar 28, 2025

Insider Transactions Reported by Christopher Ryan Sullivan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.